Ellipse Technologies' MAGnetic Expansion Control or MAGEC system has received strong recommendations from the National Institute for Health and Care Excellence, an independent body in Britain responsible for driving improvement and excellence in the health and social care system, and the British National Health Service.
The system, which received 510(k) clearance from the U.S. Food and Drug Administration in March, is a growth-friendly solution for pediatric patients, younger than 10 years, with severe progressive spinal deformities associated with thoracic insufficiency syndrome. It provides an alternative to traditional growing rods.
A medical technology guidance from NICE encouraged the NHS to use the MAGEC system in children who suffer from early onset scoliosis. This was then followed by a published draft policy by NHS with a similar endorsement.
To date, the system has been used by more than 200 surgeons in 24 countries.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018